4
Changes in Ownership
Atara Biotherapeutics, Inc. Filed Acc 0001209191-18-008505
Chief Executive Officer acquired 65,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Ciechanover Isaac E. Chief Executive Officer | 2018-02-06 | Grant or award | +65,000 | 808,675 | D: show line 1 in the form |
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Ciechanover Isaac E. Chief Executive Officer | 2018-02-06 | Grant or award · Employee Stock Option (Right to Buy) | +130,000 | 130,000 | D: show line 2 in the form |
Loading xslF345X03/doc4.xml…